Beta Drugs (India) Buy Hold or Sell Recommendation

BETA Stock   2,173  88.30  4.24%   
Assuming the 90 days trading horizon and your slightly conservative level of risk, our recommendation regarding Beta Drugs is 'Strong Sell'. A buy or sell recommendation provided by Macroaxis is an automated directive regarding whether to purchase or sell Beta Drugs given historical horizon and risk tolerance towards Beta Drugs. When Macroaxis issues a 'buy' or 'sell' recommendation for Beta Drugs, the advice is generated through an automated system that utilizes algorithms and statistical models.
  
Check out Beta Drugs Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool.
Note, we conduct extensive research on individual companies such as Beta and provide practical buy, sell, or hold advice based on investors' constraints. Beta Drugs. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

Execute Beta Drugs Buy or Sell Advice

The Beta recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Beta Drugs. Macroaxis does not own or have any residual interests in Beta Drugs or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Beta Drugs' advice using the current market data and latest reported fundamentals.

Time Horizon

Risk Tolerance

Execute Advice
Sell Beta DrugsBuy Beta Drugs
Strong Sell

Market Performance

GoodDetails

Volatility

Very steadyDetails

Hype Condition

Under hypedDetails

Current Valuation

OvervaluedDetails

Odds Of Distress

About AverageDetails

Economic Sensitivity

Moves indifferently to market movesDetails

Analyst Consensus

Not AvailableDetails

Reporting Quality (M-Score)

InapplicableDetails
For the selected time horizon Beta Drugs has a Mean Deviation of 2.96, Semi Deviation of 2.21, Standard Deviation of 3.78, Variance of 14.32, Downside Variance of 7.12 and Semi Variance of 4.9
Macroaxis provides advice on Beta Drugs to complement and cross-verify current analyst consensus on Beta Drugs. Our investment recommendation engine determines the company's potential to grow exclusively from the perspective of an investor's current risk tolerance and investing horizon.

Beta Drugs Trading Alerts and Improvement Suggestions

Beta Drugs appears to be risky and price may revert if volatility continues
Latest headline from news.google.com: Why Investors Shouldnt Be Surprised By Beta Drugs Limiteds 30 percent Share Price Surge - Simply Wall St

Beta Drugs Returns Distribution Density

The distribution of Beta Drugs' historical returns is an attempt to chart the uncertainty of Beta Drugs' future price movements. The chart of the probability distribution of Beta Drugs daily returns describes the distribution of returns around its average expected value. We use Beta Drugs price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Beta Drugs returns is essential to provide solid investment advice for Beta Drugs.
Mean Return
0.67
Value At Risk
-4.49
Potential Upside
8.63
Standard Deviation
3.78
   Return Density   
       Distribution  
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Beta Drugs historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.

Beta Drugs Greeks

Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Beta Drugs or Drugs sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Beta Drugs' price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Beta stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α
Alpha over Dow Jones
0.68
β
Beta against Dow Jones-0.16
σ
Overall volatility
3.73
Ir
Information ratio 0.14

Beta Drugs Volatility Alert

Beta Drugs currently demonstrates below-average downside deviation. It has Information Ratio of 0.14 and Jensen Alpha of 0.68. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Beta Drugs' stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Beta Drugs' stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.

Beta Drugs Market Momentum

Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Beta . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.

About Beta Drugs Buy or Sell Advice

When is the right time to buy or sell Beta Drugs? Buying financial instruments such as Beta Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.

Use Investing Ideas to Build Portfolios

In addition to having Beta Drugs in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Wholesale Thematic Idea Now

Wholesale
Wholesale Theme
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Wholesale theme has 61 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Wholesale Theme or any other thematic opportunities.
View All  Next Launch

Additional Tools for Beta Stock Analysis

When running Beta Drugs' price analysis, check to measure Beta Drugs' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Beta Drugs is operating at the current time. Most of Beta Drugs' value examination focuses on studying past and present price action to predict the probability of Beta Drugs' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Beta Drugs' price. Additionally, you may evaluate how the addition of Beta Drugs to your portfolios can decrease your overall portfolio volatility.